Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
High Sensitive ELISA Kit for Heart-type Fatty Acid Binding Protein (H-FABP)
MDGI; FABP11; H-FABP; O-FABP; Hfabp; FABP3; Fatty Acid Binding Protein 3, Muscle And Heart; Mammary Derived Growth Inhibitor; Fatty Acid Binding Protein 11; Muscle fatty acid-binding protein; Heart-ty
- Product No.HEB243Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range62.5-4,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 24.7pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 512
For more details, please contact local distributors! US$ 732 US$ 3294 US$ 6222 US$ 51240
Specificity
This assay has high sensitivity and excellent specificity for detection of High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP).
No significant cross-reactivity or interference between High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) and the recovery rates were calculated by comparing the measured value to the expected amount of High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 80-101 | 95 |
EDTA plasma(n=5) | 93-101 | 97 |
heparin plasma(n=5) | 87-96 | 92 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of High Sensitive Heart-type Fatty Acid Binding Protein (H-FABP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 98-105% | 89-96% | 78-99% | 93-103% |
EDTA plasma(n=5) | 82-95% | 93-101% | 98-105% | 96-103% |
heparin plasma(n=5) | 80-104% | 80-94% | 97-104% | 83-96% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Molecular Medicine Reports | Protective effects of N (2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion Pubmed:29393473 |
Oncology Letters | Hydrogen‑rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus‑activated kinase 2/signal transducer and activator of … Pubmed:29928398 |
FASEB Journal | Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure Pubmed: 30230922 |